Functional Brands Inc. Annual Report: A Simple Breakdown

I’m breaking down Functional Brands Inc.’s performance this year. My goal is to cut through the corporate jargon so you can decide if this company belongs in your portfolio.

1. The Big Picture

Functional Brands Inc. sells nutritional supplements. Their core business, "Kirkman," has served the special needs community since 1949, selling over 150 products—like vitamins and probiotics—to 2,000 doctors worldwide.

They recently launched "P2i," a prenatal vitamin line certified for low toxicity, and "Tru2u.health," a digital platform designed to generate steady subscription income. The company also exited the hemp and CBD business, a move that saved them $2.4 million in annual inventory and compliance costs.

2. The Money Talk

The company recently restructured its debt to clean up its balance sheet. In March 2026, they swapped expensive, high-interest preferred stock for a new "Series C" stock and $15 million in loans.

• The Benefit: This saves the company $1.5 million in annual cash payments that were previously draining their bank account.
• The Risk: The new $15 million loan charges 12% interest. Lenders now have a first claim on almost all company assets, including inventory and intellectual property. If revenue growth stalls, lenders could seize these assets, which significantly increases the risk of the company running out of cash.

3. Wins and Bumps

• The Win: The P2i prenatal line and Tru2u.health platform focus on direct-to-consumer sales with higher profit margins. P2i sells at a 20% premium over standard vitamins because of its "low toxicity" certification.
• The Bump: Nasdaq has warned the company because its stock price has traded between $0.45 and $0.75, missing the $1.00 minimum requirement. They have until June 2026 to fix this. Management may use a "reverse stock split" to boost the share price, a move that combines existing shares into fewer, more expensive ones and can sometimes lead to further price volatility.

4. Financial Health

The company is in a difficult transition. They brought in $22.8 million in revenue this year but lost $4.2 million. They currently have $1.8 million in cash on hand, which they are using to buy back old shares and pay the 12% interest on their new loan. Additionally, they lowered the number of shareholders needed to vote on company decisions from 50% to 33%, making it easier for them to pass corporate resolutions.

5. The "Watch Out" List

• Nasdaq Listing: If they are kicked off the Nasdaq, the stock will move to "Over-the-Counter" markets. This makes it harder to buy and sell shares and often causes institutional investors to sell their holdings.
• Debt Burden: The 12% interest rate costs the company $1.8 million per year. Since the company is currently losing money, this debt leaves very little room for operational mistakes.
• Regulatory Risk: The FDA does not approve their supplements. If regulators crack down on their marketing or they lose their "low toxicity" certification, sales could drop quickly.

Investor Takeaway: Functional Brands is currently a high-stakes turnaround play. You are betting on their ability to pivot toward higher-margin products like P2i and Tru2u.health before their cash runs out or they face a forced delisting from the Nasdaq. Before investing, consider whether you are comfortable with the heavy debt burden and the potential for a reverse stock split.